Metabolic Effects of Medium-Chain Fatty Acids in Patients With Medium-Chain Acyl-CoA Dehydrogenas… (NCT06623032) | Clinical Trial Compass
RecruitingNot Applicable
Metabolic Effects of Medium-Chain Fatty Acids in Patients With Medium-Chain Acyl-CoA Dehydrogenase Deficiency and Healthy Individuals
Denmark30 participantsStarted 2024-10-18
Plain-language summary
The aim of this project is to investigate the physiological effects of intake of long-chain fatty acids (LCFA) and medium-chain fatty acids (MCFA) in patients with Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD) and healthy individuals
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria MCADD patients:
* Male or female
* Age between 18-80 years old
* Diagnosed Medium-chain acyl-CoA dehydrogenase deficiency (MCADD
Inclusion Criteria Healthy Participants:
* Male or female
* Age between 18-80 years old
Exclusion Criteria both MCADD patients and healthy participants:
* Diabetes
* Kidney- or liver disease
* Use of beta blockers or diuretics
* Pregnant, lactating or planning to become pregnant within the study period
* Regular intake of substantial amounts of coconut oil, palm kernel oil or any other source abundant in MCFA
* Ongoing cancer treatment
* Metabolic or absorptive disorders, gastric bypass operation, or use of medication affecting metabolism or food absorption
* Inability, physically or mentally, to comply with the procedure required by the study protocol as evaluated by the primary investigator, study manager or clinical responsible